The evolution and understanding of skeletal complication endpoints in clinical trials of tumors with metastasis to the bone
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference113 articles.
1. Prevention and management of bone metastases in lung cancer: a review;Al Husaini;J. Thorac. Oncol.,2009
2. Analytic validation of the automated bone scan index as an imaging biomarker to standardize quantitative changes in bone scans of patients with metastatic prostate Cancer;Anand;J. Nucl. Med.,2016
3. Multisite experience of the safety, detection rate and diagnostic performance of fluciclovine ((18)F) positron emission Tomography/Computerized tomography imaging in the staging of biochemically recurrent prostate Cancer;Bach-Gansmo;J. Urol.,2017
4. Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial;Barrett-Lee;Lancet Oncol.,2014
5. Xofigo (radium-223) [prescribing information];Bayer HealthCare Pharmaceuticals Inc,2018
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy;Acta Pharmaceutica Sinica B;2024-07
2. Incidence and risk factors for bone metastases at presentation in solid tumors;Frontiers in Oncology;2024-05-10
3. Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects;Supportive Care in Cancer;2024-03
4. Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial;The Lancet Oncology;2023-06
5. Personalized (tailored) treatment with antiresorptive drugs (bisphosphonates, denosumab) in patients with bone metastases from solid tumors – A “Pico” document by Rete Oncologica Piemonte-Valle D’Aosta Bone Metastatic Disease Study Group;2023-04-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3